Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.1
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balances at beginning at Dec. 31, 2017 $ 106,937 $ 106,757,920 $ (101,036,117) $ 5,828,740
Balances at beginning (in shares) at Dec. 31, 2017 10,693,851      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation $ 532 1,230,847 1,231,379
Share-based compensation (in shares) 53,200      
Under contractual arrangements $ 250 77,250 77,500
Under contractual arrangements (in shares) 25,000      
Warrant exercises $ 2,464 534,388   536,852
Warrant exercises (in shares) 246,313      
Net loss for the year     (6,163,469) (6,163,469)
Balances at end at Dec. 31, 2018 $ 110,183 108,600,405 (107,199,586) 1,511,002
Balances at end (in shares) at Dec. 31, 2018 11,018,364      
Cumulative adjustment for adoption of new accounting standard at Dec. 31, 2019     (244) (244)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation $ 1,947 797,164   799,111
Share-based compensation (in shares) 194,694      
Warrant exercises $ 15,958 372,833   388,791
Warrant exercises (in shares) 1,595,795      
Private placement, net of offering costs $ 24,265 7,403,582   7,427,847
Private placement, net of offering costs (in shares) 2,426,455      
Net loss for the year     (5,539,790) (5,539,790)
Balances at end at Dec. 31, 2019 $ 152,353 $ 117,173,984 $ (112,739,620) $ 4,586,717
Balances at end (in shares) at Dec. 31, 2019 15,235,308